Results 201 to 210 of about 8,908 (223)
Some of the next articles are maybe not open access.
Obesity, Senescence, and Senolytics
2021Obesity is a major risk factor for the development of comorbidities such as type 2 diabetes, neurodegenerative disorders, osteoarthritis, cancer, cardiovascular and renal diseases. The onset of obesity is linked to an increase of senescent cells within adipose tissue and other organs.
Selim, Chaib +2 more
openaire +2 more sources
Chemo-Senolytic Therapeutic Potential against Angiosarcoma
Journal of Investigative Dermatology, 2023AbstractAngiosarcoma is an aggressive soft-tissue sarcoma with a poor prognosis. Chemotherapy for this cancer typically employs paclitaxel, one of the taxanes (genotoxic drugs), although it has a limited effect due to chemoresistance for prolonged treatment.
Xuebing Wang +8 more
openaire +2 more sources
The potential of Senolytics in transplantation
Mechanisms of Ageing and Development, 2021Older organs provide a substantial unrealized potential with the capacity to close the gap between demand and supply in organ transplantation. The potential of senolytics in improving age-related conditions has been shown in various experimental studies and early clinical trials. Those encouraging data may also be of relevance for transplantation.
Tomohisa Matsunaga +5 more
openaire +2 more sources
Senolytic Drugs: Implications for Clinical Practice
Advances in Gerontology, 2023The aging mechanisms study is one of the most important aims in the field of geroscience and clinical medicine. There has been a wide range of fundamental research data accumulated on this matter. The processes associated with regeneration capability decrease, age-related decline of cell proliferation and resilience are highlighted in vitro studies, as
A. K. Ilyushchenko +6 more
openaire +1 more source
Science Translational Medicine, 2020
Repurposing CAR T cells to target senescent cells ameliorates liver fibrosis and extends survival in mice with lung adenocarcinoma.
openaire +1 more source
Repurposing CAR T cells to target senescent cells ameliorates liver fibrosis and extends survival in mice with lung adenocarcinoma.
openaire +1 more source
2020
Cellular senescence is a hallmark of aging because senescent cells (SnCs) accumulate with age and play a causative role in many age-related diseases. Selectively eliminating SnCs has been emerging as a new strategy for treating age-related diseases and extending healthspan. Small molecules that targeting different SnC anti-apoptotic pathways (SCAPs) to
Yonghan He +2 more
openaire +1 more source
Cellular senescence is a hallmark of aging because senescent cells (SnCs) accumulate with age and play a causative role in many age-related diseases. Selectively eliminating SnCs has been emerging as a new strategy for treating age-related diseases and extending healthspan. Small molecules that targeting different SnC anti-apoptotic pathways (SCAPs) to
Yonghan He +2 more
openaire +1 more source
Gerosuppressive and Senolytic Nutrients
2021The aging process is intimately regulated by the contribution of interactions between genetic, epigenetic and environmental factors. Every individual is distinguished by a specific personal lifestyle, since conception, that influences the state of health, either leading to the preservation of a good state of health or accelerated aging trajectories ...
openaire +1 more source
Senolytic potential of Hsp90 inhibitors
Current Chemical Biology, 2020: Hsp90 chaperone is an encouraging target for the development of novel anticancer agents. The failure of Hsp90 inhibitors to get regulatory approval for the treatment of cancer is hindered due to toxicity, cost involved in their development and formulation issues.
Sayan Dutta Gupta, Cheol Ho Pan
openaire +1 more source
Senolytic therapy for Alzheimer’s disease
Nature Medicine, 2023Frank M, Longo, Stephen M, Massa
openaire +2 more sources